Orbis Medicines Appoints Joanne Smith-Farrell, Ph.D. as Chief Executive Officer
PRIVATEOct 27, 2026
Position
Chief Executive Officer
Company
Orbis Medicines
Joanne Smith-Farrell, Ph.D.
CopenhagenBiotechnology
Description
Orbis Medicines has appointed Joanne Smith-Farrell, Ph.D., as Chief Executive Officer. She will lead the company in advancing its innovative oral macrocycle platform and pipeline.
Who to call at Orbis Medicines, and when
A new leader at Orbis Medicines brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Orbis Medicines raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Orbis Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orbis Medicines. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Orbis Medicines
Location
Copenhagen, Capital Region Of Denmark, Denmark
About
Orbis Medicines is a biotechnology company focused on pioneering a new era for oral macrocycle drug discovery. Macrocycles are a large and diverse family of compounds with highly desirable therapeutic properties, defined by the presence of a cyclic structure. Orbis’ nGen platform is designed to systematically explore the macrocycle chemical space using a highly automated chemistry platform and deliver oral macrocycle drug candidates – nCycles – suitable for both intra- and extracellular targets. Orbis’ programs are focused on high-value oral alternatives to blockbuster biologic drugs and targets challenging for established modalities.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orbis Medicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CopenhagenBiotechnology